{
    "SPADE_UN_13459": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13459",
            "Peptide Name": "Hn-Mc (a chimeric peptide comprised of the N-terminus of HPA3NT3 and the C-terminus of melittin)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "N/A",
            "Sequence": "FKRLKKLISWIKRKRQQ",
            "Sequence Length": 17,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic construct",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Anti-inflammatory"
            ],
            "Target Organism": "[Ref.32731574]Yeast:C. albicans (MIC = 16 μM), C. krusei (MIC = 8 μM), C. parapsilosis (MIC = 16 μM), C. tropicalis (MIC = 4 μM), T. beigellii (MIC = 1 μM);Mold:T. rubrum (MIC = 1-2 μM), F. moniliforme(MIC = 1-2 μM), F. solani(MIC = 1 μM), F. oxysporum(MIC = 1-2 μM), A. flavus(MIC = 2-4 μM), A. fumigatus(MIC = 2-4 μM).[Ref.26028561] Drug-susceptible gram-negative bacteria:E. coli (MIC = 1 μM), P. aeruginosa (MIC = 2 μM);Drug-susceptible gram-positive bacteria:S. aureus (MIC = 2 μM), B. subtilis(MIC = 2 μM);Drug-resistant bacteria:P. aeruginosa DRPA-001 (MIC = 1 μM),  P. aeruginosa DRPA-002 (MIC = 1 μM),  P. aeruginosa DRPA-003 (MIC = 1 μM),  P. aeruginosa DRPA-004 (MIC = 1 μM),  P. aeruginosa DRPA-005 (MIC = 2 μM), S. aureus DRSA-001 (MIC = 2 μM), S. aureus DRSA-002 (MIC = 2 μM), S. aureus DRSA-003 (MIC = 1 μM), S. aureus DRSA-004 (MIC = 2 μM), S. aureus DRSA-005 (MIC = 2 μM).",
            "Hemolytic Activity": "[Ref.26028561] HPA3NT3 and melittin revealed the hemolysis of 68.2% and 100% at 250 μM, respectively, but Hn-Mc was 1.1% at the same concentration",
            "Cytotoxicity": "[Ref.26028561] The IC50 of HPA3NT3, melittin and Hn-Mc against HaCaT cells were 49.5, 2.8 and 357.5 μM, respectively",
            "Binding Target": "Mitochondria (possibily)",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Hn-Mc adopted a random coil structure in the SUVs containing a mammalian membrane and in the buffer; however, it adopted an α-helical structure in SUVs containing a fungal membrane, indicating that it was not bound to the mammalian membrane but rather adhered to or inserted in the fungal membrane.",
            "Formula": "C105H182N34O21",
            "Mass": 2256.78,
            "PI": 12.0,
            "Net Charge": 8,
            "Hydrophobicity": -1.31,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Comments": "Hn-Mc has a high affinity for the fungal plasma membrane and induces apoptosis in fungal cells, and provide guidance for the development of new antifungal agents. Hn-Mc is an excellent model peptide with potent antibacterial activity and non-cytotoxicity.",
            "Literature": [
                {
                    "Title": "Antifungal Effect of A Chimeric Peptide Hn-Mc against Pathogenic Fungal Strains.",
                    "Pubmed ID": "32731574",
                    "Reference": "Antibiotics (Basel). 2020 Jul 28;9(8)454. doi 10.3390/antibiotics9080454.",
                    "Author": "Kim JY, Park SC, Noh G, Kim H, Yoo SH, Kim IR, Lee JR, Jang MK.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32731574"
                },
                {
                    "Title": "Novel chimeric peptide with enhanced cell specificity and anti-inflammatory activity.",
                    "Pubmed ID": "26028561",
                    "Reference": "Biochem Biophys Res Commun. 2015 Jul 31;463(3)322-8. doi 10.1016/j.bbrc.2015.05.063. Epub 2015 May 29.",
                    "Author": "Young-Min Kim, Nam-Hong Kim, Jong-Wan Lee, Jin-Sun Jang, Yung-Hoon Park, Seong-Cheol Park, Mi-Kyeong Jang",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=26028561"
                },
                {
                    "Title": "novel chimeric peptide with enhanced cell specificity and anti-inflammatory activity",
                    "Pubmed ID": "",
                    "Author": "Kim YM, Kim nH, Lee JW, Jang JS, Park YH, Park SC, Jang MK"
                }
            ],
            "Frequent Amino Acids": "KRI",
            "Absent Amino Acids": "ACDEGHMNOPTUVY",
            "Basic Residues": 8,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 6,
            "Polar Residues": 11,
            "Positive Residues": 8,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_12040",
                    "Similarity": 0.8,
                    "Sequence": "RRLRKKTRKRLK"
                },
                {
                    "SPADE_ID": "SPADE_UN_12041",
                    "Similarity": 0.8,
                    "Sequence": "RWLRKWTRKRLK"
                },
                {
                    "SPADE_ID": "SPADE_UN_30437",
                    "Similarity": 0.8,
                    "Sequence": "GLKKLISWIKRAAQQG"
                }
            ]
        }
    }
}